Progression‐free survival · non‐small cell lung cancer in the elderly population
Non‐platinum single‐agent may leads to lower progression‐free survival compared with non‐platinum combination treatment (low certainty).
1 finding from 1 review
Objective response rate · non‐small cell lung cancer in the elderly population
Non‐platinum single‐agent may leads to higher objective response rate (ORR) compared with non‐platinum combination treatment (low certainty).
1 finding from 1 review
Grade 3 and 4 hematological adverse events (AE) ‐ anemia · non‐small cell lung cancer in the elderly population
It is very uncertain whether non‐platinum single‐agent changes grade 3 and 4 hematological adverse events (AE) ‐ anemia compared with non‐platinum combination treatment (very low certainty).
1 finding from 1 review
Grade 3 to 4 neutropenia · non‐small cell lung cancer in the elderly population
Non‐platinum single‐agent may leads to higher grade 3 and 4 hematological adverse events (AE) ‐ neutropenia compared with non‐platinum combination treatment (low certainty).
1 finding from 1 review
Safety (AE, adverse drug reaction): thrombocytopenia Grades 3 or 4 according to National Cancer Institute · non‐small cell lung cancer in the elderly population
It is very uncertain whether non‐platinum single‐agent changes grade 3 and 4 hematological adverse events (AE) ‐ thrombocytopenia compared with non‐platinum combination treatment (very low certainty).
1 finding from 1 review
QoL · non‐small cell lung cancer in the elderly population
1 finding from 1 review
Overall survival · non‐small cell lung cancer in the elderly population
Non‐platinum therapies probably leads to lower overall survival compared with platinum combination (moderate certainty).
1 finding from 1 review
Long‐term mortality · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
Mortality before hospital discharge · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
It is very uncertain whether inhaled nitric oxide changes mortality prior to discharge1 compared with placebo or conventional therapy (very low certainty).
1 finding from 1 review
Difference in MPAP change score (SE) ‐ Conventional Management4 · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
Difference in MPAP change score (SE) ‐ Placebo4 · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
no estimate extracted
1 study · 2 participants
Very low
Difference in MAP change score (SE) ‐ Conventional Mangement4 · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
Difference in MAP change score (SE) ‐ Placebo4 · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
no estimate extracted
1 study · 2 participants
Very low
Intervention not reported
Respiratory failure · postoperative pulmonary complications in upper abdominal surgery
The intervention showed no clear difference in respiratory failure (low certainty).
1 finding from 1 review
Intervention not reported
Clinical complications · postoperative pulmonary complications in upper abdominal surgery
The intervention showed no clear difference in clinical complications (low certainty).
1 finding from 1 review
Change in peak work capacity · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Exercise capacity: percentage change constant work rate endurance time Constant work rate cycle endurance test · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Exercise capacity · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Health‐related quality of life Change in total score of St George Respiratory Questionnaire · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Physical activity: not measured · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found